A post-marketing surveillance of the real-world safety and effectiveness of avelumab in patients with curatively unresectable Merkel cell carcinoma in Japan

被引：2

作者：

Yamazaki, N. ^{[1
]}

Kiyohara, Y. ^{[2
]}

Sato, M. ^{[3
]}

Endo, S. ^{[4
]}

Song, B. ^{[5
]}

Tanaka, Y. ^{[6
]}

Kambe, A. ^{[7
]}

Sato, Y. ^{[6
]}

Uhara, H. ^{[8
]}

机构：

[1] Natl Canc Ctr, Dermatol Oncol Dept, Tsukiji Campus,Chuo Ku, Tokyo, Japan

[2] Shizuoka Canc Ctr, Div Dermatol, Shizuoka, Japan

[3] Merck Biopharma Co Ltd, Biostat, Meguro Ku, Tokyo, Japan

[4] Merck Biopharma Co Ltd, Dev Safety Japan, Meguro Ku, Tokyo, Japan

[5] Merck Biopharma Co Ltd, Clin Data Sci, Meguro Ku, Tokyo, Japan

[6] Merck Biopharma Co Ltd, Affairs Sect, Meguro Ku, Tokyo, Japan

[7] Merck Biopharma Co Ltd, PMS, Meguro Ku, Tokyo, Japan

[8] Sapporo Med Univ, Dept Dermatol, Sch Med, Sapporo, Hokkaido, Japan

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷

关键词：

D O I：

10.1016/j.annonc.2022.10.438

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

407P

引用

页码：S1601 / S1602

页数：2

共 50 条

[31] Safety and effectiveness of pembrolizumab monotherapy in Japanese patients with unresectable urothelial carcinoma: a nation-wide post-marketing surveillance
Hiroyuki Nishiyama
Yu Tanaka
Masahiro Hamada
Masahiko Ozaki
Toshihiko Minegishi
Yuichiro Ito
Shinichiroh Maekawa
Nobuyuki Yamamoto
[J]. BMC Cancer, 23
[32] Avelumab for advanced Merkel cell carcinoma in the Netherlands: a real-world cohort
Levy, Sonja
Aarts, Maureen J. B.
Eskens, Ferry A. L. M.
Keymeulen, Kristien B. M., I
Been, Lukas B.
Grunhagen, Dirk
van Akkooi, Alexander
Jalving, Mathilde
Tesselaar, Margot E. T.
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
[33] Safety and effectiveness of pembrolizumab monotherapy in Japanese patients with unresectable urothelial carcinoma: a nation-wide post-marketing surveillance
Nishiyama, Hiroyuki
Tanaka, Yu
Hamada, Masahiro
Ozaki, Masahiko
Minegishi, Toshihiko
Ito, Yuichiro
Maekawa, Shinichiroh
Yamamoto, Nobuyuki
[J]. BMC CANCER, 2023, 23 (01)
[34] Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan
Hayase, Naomi
Yamada, Mariko
Kaneko, Shuhei
Watanabe, Yoko
[J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (06) : 660 - 673
[35] Safety and effectiveness of riociguat for chronic thromboembolic pulmonary hypertension in real-world clinical practice: interim data from post-marketing surveillance in Japan
Tanabe, Nobuhiro
Ogo, Takeshi
Hatano, Masaru
Kigawa, Ayaka
Sunaya, Toshiyuki
Sato, Shoichiro
[J]. PULMONARY CIRCULATION, 2020, 10 (03)
[36] Safety and effectiveness of dupilumab in the real-world treatment of atopic dermatitis in Japan: 1-year interim analysis from a post-marketing surveillance
Saeki, Hidehisa
Fujita, Hiroyuki
Suzuki, Katsuhisa
Arima, Kazuhiko
[J]. JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (03) : 78 - 87
[37] Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan
Naomi Hayase
Mariko Yamada
Shuhei Kaneko
Yoko Watanabe
[J]. Clinical and Experimental Nephrology, 2021, 25 : 660 - 673
[38] Real-world safety and effectiveness of intravenous fomepizole in patients with ethylene glycol and methanol poisoning in Japan: results of a 7-year post-marketing surveillance study
Yoshioka, Toshiharu
Koyanagi, Momoha
Yoshida, Naoki
[J]. EXPERT OPINION ON DRUG SAFETY, 2024,
[39] Real-world effectiveness of eculizumab in generalized myasthenia gravis in Japan: 1-year post-marketing surveillance data
Murai, Hiroyuki
Suzuki, Shigeaki
Fukamizu, Yuji
Osawa, Takehiko
Kikui, Hidekazu
Utsugisawa, Kimiaki
[J]. NEUROLOGY, 2022, 98 (18)
[40] Post-marketing surveillance of the safety of levofloxacin in Japan
Yamaguchi, Hiroki
Kawai, Hitomi
Matsumoto, Takuyuki
Yokoyama, Hiroo
Nakayasu, Toshio
Komiya, Masahiro
Shimada, Jingoro
[J]. CHEMOTHERAPY, 2007, 53 (02) : 85 - 103

← 1 2 3 4 5 →